FY 24 has not been particularly rewarding for investors in banking stocks after a bumper FY 23 – Chandrachoodamani makes sense of the numbers and more!
Should you bank on banking stocks? Earnings review and more Read More »
The NPS Scheme has been evolving over the years and we think that, in its current avatar, it is a good way to prepare for retirement.
What makes the NPS scheme a good way to prepare for retirement Read More »
This article is Part 4 of our asset allocation series.
How much should you allocate to gold? Read More »
Spotting sector opportunities is far from easy. Chandrachoodamani takes you through his journey of picking, tracking and identifying opportunities in a sector!
8 steps to identify sector opportunities – from breakout to maturity Read More »
The best asset allocation for goals that are 3 / 5 / 10 years away.
What asset allocation best fits 10-year, 5-year and 3-year goals? Read More »
Quarterly review and changes to Prime Portfolios – a set of eighteen unique portfolios that meet several investor timeframes and needs.
Quarterly Review – Changes to Prime Portfolios Read More »
What is the best asset allocation for you to target – a sequel to our article on whether an all-equity portfolio will work.
70/30, 60/40 or 50/50: Which is the best asset allocation? Read More »
All your questions on reviewing your MF portfolio, covering frequency, spotting under-performers and dealing with them, answered here.
How to review your mutual fund portfolio Read More »
A deep dive into Prime Trends – Consumption, our portfolio of stocks on smallcase, designed to profit from the uptick in discretionary consumption.
Prime Trends – Consumption: A Comprehensive Guide Read More »
Can you have a 100% equity portfolio and do away with all other asset classes? Aarati Krishnan & Bipin Ramachandran turn to the data for answers.
A 100% equity portfolio: Will it work? Read More »
With the Sensex zooming past 70k, if you are wondering whether to book profits, then you should read this.
How to book profits in your mutual fund portfolio Read More »
Taking a loan against mutual fund investments without breaking them can seem like an attractive option to tide over a temporary cash crunch. Aarati Krishnan evaluates the merits of this financing arrangement.
Should you go for loan against mutual funds? Read More »
The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research services before onboarding. History, Present business and Background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services. Terms and conditions of Research Services: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Analyst never guarantees the returns on the recommendation provided. Investor shall take note that Investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The Research Analyst shall not be responsible for any loss to the Investors. Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made there under against the Research Analyst relating to Research Analyst services. Details of its associates: No associates. Disclosures with respect to Research and Recommendations Services: The Research Analyst or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of Research Analyst services. Such conflict of interest shall be disclosed to the client as and when they arise. Research Analyst or its directors or its employee or its associates have not received any compensation from the company which is subject matter of recommendation. Research Analyst or its directors or its employee or its associates have not managed or co-managed the public offering of any company. Research Analyst or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation. The subject company was not a client of Research Analyst or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided. Research Analysts or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.
Full disclosures and disclaimers
Compliance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Grievance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
